Anacor Pharma Receives $17.7M Investment from Gates Foundation
April 08, 2013 at 08:31 AM EDT
Anacor Pharmaceuticals (NASDAQ: ANAC ) today announced that it has signed a research agreement with the Bill & Melinda Gates Foundation (the Gates Foundation) to discover drug candidates intended to treat two filarial worm diseases (onchocerciasis, or river blindness, and lymphatic filariasis, commonly known as elephantiasis) and tuberculosis (TB). Additionally, Anacor will create an